Xinhua Pharmaceutical: Obtained the registration certificate for concentrated solution of sodium potassium magnesium calcium injection.

Xinhua Pharmaceuticals announced that the company recently received the "Drug Registration Certificate" for the concentrated solution of sodium-potassium-magnesium-calcium injection approved and issued by the National Medical Products Administration. This drug is a Class 3 prescription medication of chemical origin, with a specification of 20ml. It is used for electrolyte supplementation when infusing solutions containing concentrated glucose or amino acids through central venous administration, in order to maintain electrolyte dynamics balance in adult patients. This product has not been imported overseas, and domestic manufacturers have just obtained approval, so it has not been launched for widespread sales yet.